Pre-order Enquiry
Request Free Sample
Global Postmenopausal Vaginal Atrophy (PVA) Treatment Key Trends and Opportunities to 2027
SKU ID : QYR-18699539 | Publishing Date : 06-Jul-2021 | No. of pages : 184
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Postmenopausal Vaginal Atrophy (PVA) Treatment Key Trends and Opportunities to 2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Systemic Estrogen Treatments
1.2.3 Non-estrogenic Therapies
1.3 Market by Application
1.3.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trend
2.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Perspective (2016-2027)
2.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Growth Trends by Regions
2.2.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Postmenopausal Vaginal Atrophy (PVA) Treatment Historic Market Size by Regions (2016-2021)
2.2.3 Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Industry Trends
2.3.2 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Drivers
2.3.3 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Challenges
2.3.4 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postmenopausal Vaginal Atrophy (PVA) Treatment Players by Market Size
3.1.1 Players Covered: Ranking by Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue
3.1.2 Global Top Postmenopausal Vaginal Atrophy (PVA) Treatment Players by Revenue (2016-2021)
3.1.3 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Players (2016-2021)
3.1.4 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Concentration Ratio
3.2.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in 2020
3.3 Postmenopausal Vaginal Atrophy (PVA) Treatment Key Players Head office and Area Served
3.4 Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Product Solution and Service
3.5 Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Breakdown Data by Type (2016-2027)
4.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Type (2022-2027)
5 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Breakdown Data by Application (2016-2027)
5.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Historic Market Size by Application (2016-2021)
5.2 Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
6.2 Key Postmenopausal Vaginal Atrophy (PVA) Treatment Players Market Share in North America (2020-2021)
6.3 North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country
6.3.1 North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2016-2021)
6.3.2 North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Country (2022-2027)
6.4 U.S. Market Size Analysis
6.4.1 U.S. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
6.4.2 U.S. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
6.4.3 U.S. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
6.5.2 Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
6.5.3 Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
7 Europe
7.1 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.2 Key Postmenopausal Vaginal Atrophy (PVA) Treatment Players Market Share in Europe (2020-2021)
7.3 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country
7.3.1 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2016-2021)
7.3.2 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.4.2 Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
7.4.3 Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.5.2 France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
7.5.3 France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.6.2 U.K. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
7.6.3 U.K. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.7.2 Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
7.7.3 Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
7.8.2 Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
7.8.3 Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8 Asia-Pacific
8.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.2 Key Postmenopausal Vaginal Atrophy (PVA) Treatment Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region
8.3.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region (2016-2021)
8.3.2 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.4.2 China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.4.3 China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.5.2 Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.5.3 Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.6.2 South Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.6.3 South Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.7.2 India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.7.3 India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.8.2 Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.8.3 Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.9.2 Taiwan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.9.3 Taiwan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.10.2 Indonesia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.10.3 Indonesia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.11.2 Thailand Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.11.3 Thailand Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.12.2 Malaysia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.12.3 Malaysia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.13 Philippines Market Size Analysis
8.13.1 Philippines Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.13.2 Philippines Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.13.3 Philippines Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
8.14.2 Vietnam Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
8.14.3 Vietnam Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
9 Latin America
9.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
9.2 Key Postmenopausal Vaginal Atrophy (PVA) Treatment Players Market Share in Latin America (2020-2021)
9.3 Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country
9.3.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2016-2021)
9.3.2 Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
9.4.2 Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
9.4.3 Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
9.5.2 Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
9.5.3 Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
9.6.2 Argentina Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
9.6.3 Argentina Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
10 Middle East & Africa
10.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
10.2 Key Postmenopausal Vaginal Atrophy (PVA) Treatment Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country
10.3.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2016-2021)
10.3.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
10.4.2 Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
10.4.3 Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
10.5.2 Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
10.6 UAE Market Size Analysis
10.6.1 UAE Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (2016-2027)
10.6.2 UAE Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2027)
10.6.3 UAE Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2027)
11 Key Players Profiles
11.1 EndoCeutics
11.1.1 EndoCeutics Company Details
11.1.2 EndoCeutics Business Overview and Its Total Revenue
11.1.3 EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.1.4 EndoCeutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.1.5 EndoCeutics Recent Development
11.2 Upsher-Smith Laboratories
11.2.1 Upsher-Smith Laboratories Company Details
11.2.2 Upsher-Smith Laboratories Business Overview and Its Total Revenue
11.2.3 Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.2.4 Upsher-Smith Laboratories Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.2.5 Upsher-Smith Laboratories Recent Development
11.3 TherapeuticsMD
11.3.1 TherapeuticsMD Company Details
11.3.2 TherapeuticsMD Business Overview and Its Total Revenue
11.3.3 TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.3.4 TherapeuticsMD Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.3.5 TherapeuticsMD Recent Development
11.4 Bionovo
11.4.1 Bionovo Company Details
11.4.2 Bionovo Business Overview and Its Total Revenue
11.4.3 Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.4.4 Bionovo Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.4.5 Bionovo Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview and Its Total Revenue
11.5.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.5.4 Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Details
11.6.2 Novo Nordisk Business Overview and Its Total Revenue
11.6.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.6.4 Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.6.5 Novo Nordisk Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Allergan Business Overview and Its Total Revenue
11.7.3 Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.7.4 Allergan Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.7.5 Allergan Recent Development
11.8 Shionogi
11.8.1 Shionogi Company Details
11.8.2 Shionogi Business Overview and Its Total Revenue
11.8.3 Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.8.4 Shionogi Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.8.5 Shionogi Recent Development
11.9 Ligand Pharmaceuticals
11.9.1 Ligand Pharmaceuticals Company Details
11.9.2 Ligand Pharmaceuticals Business Overview and Its Total Revenue
11.9.3 Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.9.4 Ligand Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.9.5 Ligand Pharmaceuticals Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview and Its Total Revenue
11.10.3 Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.10.4 Bayer Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Pantarhei Bioscience
11.11.1 Pantarhei Bioscience Company Details
11.11.2 Pantarhei Bioscience Business Overview and Its Total Revenue
11.11.3 Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.11.4 Pantarhei Bioscience Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.11.5 Pantarhei Bioscience Recent Development
11.12 Foamix Pharmaceuticals
11.12.1 Foamix Pharmaceuticals Company Details
11.12.2 Foamix Pharmaceuticals Business Overview and Its Total Revenue
11.12.3 Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.12.4 Foamix Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.12.5 Foamix Pharmaceuticals Recent Development
11.13 Pep-Tonic Medical
11.13.1 Pep-Tonic Medical Company Details
11.13.2 Pep-Tonic Medical Business Overview and Its Total Revenue
11.13.3 Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.13.4 Pep-Tonic Medical Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.13.5 Pep-Tonic Medical Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Details
11.14.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
11.14.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Introduction
11.14.4 Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021)
11.14.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
List of Figures, Tables and Charts Available in Global Postmenopausal Vaginal Atrophy (PVA) Treatment Key Trends and Opportunities to 2027
List of TablesTable 1. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
Table 2. Key Players of Systemic Estrogen Treatments
Table 3. Key Players of Non-estrogenic Therapies
Table 4. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Regions (2016-2021)
Table 8. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Regions (2022-2027)
Table 10. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Trends
Table 11. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Drivers
Table 12. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Challenges
Table 13. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Restraints
Table 14. Ranking of Global Top Postmenopausal Vaginal Atrophy (PVA) Treatment Manufacturers by Revenue (US$ Million) in 2020
Table 15. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Players (2016-2021)
Table 17. Global Top Postmenopausal Vaginal Atrophy (PVA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment as of 2020)
Table 18. Global 5 Largest Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue (CR5 and HHI) (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Product Solution and Service
Table 21. Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 24. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 26. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Type (2022-2027)
Table 27. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 28. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 30. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Application (2022-2027)
Table 31. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in North America (2020-2021) (US$ Million)
Table 32. North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2016-2021) & (US$ Million)
Table 33. North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Share by Countries (2016-2021)
Table 34. North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2022-2027) & (US$ Million)
Table 35. North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Share by Countries (2022-2027)
Table 36. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021)
Table 37. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027)
Table 38. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021)
Table 39. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027)
Table 40. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
Table 41. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
Table 42. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
Table 43. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
Table 44. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Europe (2020-2021) (US$ Million)
Table 45. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2016-2021) & (US$ Million)
Table 46. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Share by Countries (2016-2021)
Table 47. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2022-2027) & (US$ Million)
Table 48. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Share by Countries (2022-2027)
Table 49. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
Table 50. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
Table 51. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
Table 52. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
Table 53. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
Table 54. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
Table 55. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
Table 56. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
Table 57. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
Table 58. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
Table 59. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
Table 60. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
Table 61. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
Table 62. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
Table 63. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
Table 64. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
Table 65. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
Table 66. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
Table 67. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
Table 68. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
Table 69. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Asia-Pacific (2020-2021) (US$ Million)
Table 70. Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 71. Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions (2022-2027) & (US$ Million)
Table 72. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
Table 73. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
Table 74. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
Table 75. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
Table 76. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
Table 77. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
Table 78. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
Table 79. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
Table 80. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
Table 81. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
Table 82. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
Table 83. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
Table 84. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
Table 85. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
Table 86. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
Table 87. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
Table 88. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
Table 89. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
Table 90. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
Table 91. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
Table 92. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021)
Table 93. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027)
Table 94. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021)
Table 95. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027)
Table 96. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
Table 97. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
Table 98. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
Table 99. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
Table 100. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Latin America (2020-2021) (US$ Million)
Table 101. Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2016-2021) & (US$ Million)
Table 102. Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2022-2027) & (US$ Million)
Table 103. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
Table 104. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
Table 105. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
Table 106. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
Table 107. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
Table 108. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
Table 109. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
Table 110. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
Table 111. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
Table 112. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
Table 113. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
Table 114. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
Table 115. Key Players Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Middle East & Africa (2020-2021) (US$ Million)
Table 116. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2016-2021) & (US$ Million)
Table 117. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Countries (2022-2027) & (US$ Million)
Table 118. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
Table 119. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
Table 120. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
Table 121. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
Table 122. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
Table 123. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
Table 124. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
Table 125. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
Table 126. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
Table 127. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
Table 128. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
Table 129. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
Table 130. EndoCeutics Company Details
Table 131. EndoCeutics Business Overview
Table 132. EndoCeutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 133. EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 134. EndoCeutics Recent Development
Table 135. Upsher-Smith Laboratories Company Details
Table 136. Upsher-Smith Laboratories Business Overview
Table 137. Upsher-Smith Laboratories Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 138. Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 139. Upsher-Smith Laboratories Recent Development
Table 140. TherapeuticsMD Company Details
Table 141. TherapeuticsMD Business Overview
Table 142. TherapeuticsMD Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 143. TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 144. TherapeuticsMD Recent Development
Table 145. Bionovo Company Details
Table 146. Bionovo Business Overview
Table 147. Bionovo Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 148. Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 149. Bionovo Recent Development
Table 150. Pfizer Company Details
Table 151. Pfizer Business Overview
Table 152. Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 153. Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 154. Pfizer Recent Development
Table 155. Novo Nordisk Company Details
Table 156. Novo Nordisk Business Overview
Table 157. Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 158. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 159. Novo Nordisk Recent Development
Table 160. Allergan Company Details
Table 161. Allergan Business Overview
Table 162. Allergan Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 163. Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 164. Allergan Recent Development
Table 165. Shionogi Company Details
Table 166. Shionogi Business Overview
Table 167. Shionogi Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 168. Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 169. Shionogi Recent Development
Table 170. Ligand Pharmaceuticals Company Details
Table 171. Ligand Pharmaceuticals Business Overview
Table 172. Ligand Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 173. Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 174. Ligand Pharmaceuticals Recent Development
Table 175. Bayer Company Details
Table 176. Bayer Business Overview
Table 177. Bayer Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 178. Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 179. Bayer Recent Development
Table 180. Pantarhei Bioscience Company Details
Table 181. Pantarhei Bioscience Business Overview
Table 182. Pantarhei Bioscience Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 183. Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 184. Pantarhei Bioscience Recent Development
Table 185. Foamix Pharmaceuticals Company Details
Table 186. Foamix Pharmaceuticals Business Overview
Table 187. Foamix Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 188. Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 189. Foamix Pharmaceuticals Recent Development
Table 190. Pep-Tonic Medical Company Details
Table 191. Pep-Tonic Medical Business Overview
Table 192. Pep-Tonic Medical Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 193. Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 194. Pep-Tonic Medical Recent Development
Table 195. Teva Pharmaceuticals Company Details
Table 196. Teva Pharmaceuticals Business Overview
Table 197. Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment Business (2016-2021) & (US$ Million)
Table 198. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product
Table 199. Teva Pharmaceuticals Recent Development
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Type: 2020 & 2027
Figure 2. Systemic Estrogen Treatments Features
Figure 3. Non-estrogenic Therapies Features
Figure 4. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Application: 2020 & 2027
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Postmenopausal Vaginal Atrophy (PVA) Treatment Report Years Considered
Figure 8. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Regions: 2016 VS 2021 VS 2027
Figure 9. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth 2016-2027 (US$ Million)
Figure 10. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Regions (2022-2027)
Figure 11. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Share by Players in 2020
Figure 12. Global Top Postmenopausal Vaginal Atrophy (PVA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Treatment as of 2020)
Figure 13. The Top 10 and 5 Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in 2020
Figure 14. North America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 15. U.S. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 16. Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 17. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. U.K. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. South Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Taiwan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Indonesia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Thailand Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Malaysia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Philippines Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Vietnam Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Latin America Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Argentina Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. UAE Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Keyplayers in Global Postmenopausal Vaginal Atrophy (PVA) Treatment Key Trends and Opportunities to 2027
EndoCeuticsUpsher-Smith Laboratories
TherapeuticsMD
Bionovo
Pfizer
Novo Nordisk
Allergan
Shionogi
Ligand Pharmaceuticals
Bayer
Pantarhei Bioscience
Foamix Pharmaceuticals
Pep-Tonic Medical
Teva Pharmaceuticals
